Headquarters
245 MAIN ST FL 2, CAMBRIDGE, MA 02142-1064, US
CAMBRIDGE, MA, US
EIKONIZO THERAPEUTICS, INC.
From the company
Eikonizo is a therapeutics company developing disease-modifying therapies by creating brain penetrant and peripherally-restricted small molecules to improve the treatment of human disease. Its pipeline focuses on highly selective next-generation small molecule inhibitors of HDAC6, a cytoplasmic lysine deacetylase central to intracellular transport, signaling and proteostasis, aimed at neurodegenerative and cardiorenal diseases.
Products & services offered
Capabilities 2
Facilities
Send your requirements
Quantities, certifications, and timing.